Alric, L <br/><br/>
Pilot study of interferon-alpha-ribavirin-interleukin-2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus genotype 1.  [electronic resource] 

 -  Journal of viral hepatitis  Feb 2006 
 - 139-44 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1352-0504 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2893.2005.00694.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--administration & dosage<br/>Drug Therapy, Combination<br/>Female<br/>France<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Injections, Subcutaneous<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Interleukin-2--administration & dosage<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Recombinant Proteins<br/>Ribavirin--administration & dosage<br/>Species Specificity<br/>Treatment Outcome<br/>Viral Load